Design of strategies to study the metabolic profile of highly polar compounds in plasma by reversed-phase liquid chromatography-high resolution mass spectrometry by Sánchez López, Elena et al.








This work is licensed under a  
Creative Commons Attribution-NonCommercial-NoDerivatives  
4.0 International License. 
       
 
 
Document downloaded from the institutional repository of the University of 
Alcala: https://ebuah.uah.es/dspace/ 
 
This is a postprint version of the following published document: 
 
Sánchez-López, Elena, Crego, Antonio L & Marina, María Luisa, 2017. Design 
of strategies to study the metabolic profile of highly polar compounds in 
plasma by reversed-phase liquid chromatography–high resolution mass 
spectrometry. Journal of Chromatography A, 1490, pp.156–165. 
 











(Article begins on next page) 
Accepted Manuscript
Title: DESIGN OF STRATEGIES TO STUDY THE
METABOLIC PROFILE OF HIGHLY POLAR
COMPOUNDS IN PLASMA BY REVERSED-PHASE
LIQUID CHROMATOGRAPHY-HIGH RESOLUTION
MASS SPECTROMETRY









Please cite this article as: Elena Sánchez-López, Antonio L.Crego, Marı́a Luisa
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 For the first time FMOC is used to label plasma in LC-MS. 
 A larger number of FMOC compounds retained in RPLC than underivatized in 
HILIC. 
 Ultrafiltration (UF) generate more plasma features than protein precipitation 
(PP). 
 The UF approach offers better repeatability than the PP method. 
 
Abstract 
 Amino acids and related compounds are paramount analytes which are involved 
in numerous metabolic pathways. Most of these compounds are unable to be retained on 
Liquid Chromatography with Reversed-Phase stationary phases due to their high 
hydrophilic character. An interesting strategy is to reduce their polarity through their 
derivatization with a labelling reagent, such as the commercially available 9-
fluorenylmethyloxycarbonyl (FMOC) which forms stable complexes with primary and 
secondary amine moieties rapidly. Although some derivatization reagents have been 
employed in the study of metabolic profiles, as far as we know, FMOC has never been 
employed for this purpose. In this work, it is demonstrated that the use of RP-LC(C18)-
MS(TOF) using a C18 column and FMOC as labelling agent enables the determination 
of a larger number of hydrophilic compounds (proteinogenic amino acids, non-
proteinogenic amino acids, and biogenic amines) when compared to the use of a fully-
wettable pentafluorophenyl column in fully-aqueous conditions (gradient starting in 0% 
of organic solvent) and HILIC column, both without using compound derivatization. 
Different strategies for plasma protein elimination were also carefully evaluated. 
Results revealed that ultrafiltration (UF) offered a lower variability from sample to 
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sample when compared to the protein precipitation (PP) method (from 2 to 12 times 
lower variability found in UF). Additionally, UF preserved a larger number of possible 
compounds when compared to the PP approach: 4631 unique molecular features with 
UF, 666 unique molecular features with PP.  
Keywords: 9-fluorenylmethyloxycarbonyl / hydrophilic compounds / liquid 





Amino acids and their metabolites are organic molecules with high importance 
in many biological pathways, they serve as building blocks for proteins, and they play 
important roles in neurotransmitter transport and biosynthesis of several other essential 
biomolecules. As a consequence, they act as biomarkers of different disorders and can 
even aid in the early detection of a disease, as demonstrated in several metabolomics 
studies [1-3]. Metabolomics is the latest of the ‘omics’ to be implemented after 
transcriptomics, proteomics, and genomics and it is referred to the study of the 
metabolome, i.e. the study of low molecular weight compounds which are involved in 
numerous biochemical processes in a biological system such as biological fluids, 
tissues, cells, or even in a whole organism [4]. In metabolomics, two main distinctions 
are made: targeted and untargeted approaches. Targeted approaches aim their efforts on 
the quantitation of a specific subset of known metabolites, whereas untargeted 
approaches are focused on the global and unbiased analysis of the small molecules that 
constitute the metabolome. The latter approach is also known as global metabolite 
profiling [5]. Metabolic profiles provide useful information related to the state of an 
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organism as they are directly related to the cellular activity and are correlated with 
phenotype in a more direct manner than the rest of the ‘omics’ [6]. 
Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) are the most 
used strategies to carry out metabolomics studies, being widely employed for this 
purpose. NMR is largely used in metabolomics due to its numerous advantages derived 
from the fact that it requires minimum sample preparation, is rapid, quantitative, 
nondestructive, offers good reproducibility and high throughput analysis, however, its 
main drawback is its low sensitivity [7,8]. On the contrary, MS provides much higher 
sensitivity and it can be easily coupled to a separation technique such as Liquid 
Chromatography (LC), Gas Chromatography (GC), or Capillary Electrophoresis (CE), 
enhancing its selectivity and effectiveness. Among these techniques, LC-MS remains 
the technique of choice in untargeted metabolomics thanks to its robustness, 
reproducibility, applicability and sensitivity, especially in the reversed-phase (RP) mode 
[9,10]. 
Unfortunately, the determination of highly polar compounds, such as amino 
acids and related compounds, cannot be performed on traditional RP stationary phases, 
such as C18 columns, due to the fact that they have low or null retention. To solve this 
issue, different alternative strategies can be carried out, such as the use of polar-
embedded and polar-endcapped stationary phases, hydrophilic interaction liquid 
chromatography (HILIC), the addition of ion-pairing agents to the mobile phase, or 
even by increasing the hydrophobicity of these compounds by means of derivatization 
approaches and further analysis by RP liquid chromatography (RPLC). Polar-embedded 
and polar-endcapped stationary phases have an increased stability in highly aqueous 
mobile phases due to their hydrogen-bonding ability, offering an alternative selectivity 
to C18 columns by enabling the retention of polar compounds [11]. HILIC has become 
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an attractive alternative to RPLC in the last years thanks to its numerous advantages 
such as having an increased analyte diffusivity in the organic-rich mobile phase [12], a 
lower backpressure as a consequence of the low viscosity of the mobile phase [13], and 
an enhanced MS signal due to the better eluent desolvation [14], among others. 
Although this approach is perfectly suitable for polar metabolome analysis being often 
used in combination with RPLC due to their orthogonality [15], HILIC is associated 
with higher variability in retention times, low peak efficiency, and long re-equilibration 
times after gradient elution [6,16]. On the other hand, the addition of ion-pairing agents 
may lead to ion-suppression problems and system contamination [17]. Another option is 
to increase their hydrophobicity by a derivatization step, so that they can interact with 
the RPLC stationary phase. Derivatization is an interesting approach not only to 
improve the chromatographic performance, but also to enhance the sensitivity in MS 
due to the formation of a compound having higher values of m/z. Moreover, 
derivatization also improves the selectivity due to the possibility of having more 
characteristic fragments of the compounds under study. 
Thus, RPLC methodologies including a derivatization step have been reported in 
the study of metabolic profiles using different labelling reagents, such as 4-(N,N-
dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (DBD-F) [18], 6-
aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) [19], phenylisothiocyanate 
(PITC) [20,21],  aminooxy-N-(3-perfluorooctyl-propyl)acetamide [22], the metallic tag 
bis(2,2’-bipyridine)-4’-methyl-4-carboxybipyridine-ruthenium N-succinimidyl ester-
bis(hexafluorophosphate) (Rub2m-O-Su) [23], some novel non-commercially available 
derivatization reagents [24-26], 3,5-dinitrosalicylic acid (DNS) [27-29], and other 
chemical isotope labelling reagents [30]. Some of these labelling reagents have several 
drawbacks, for instance, DNS suffers from long reaction times and produces 
6 
 
photosensitive adducts [19]. The rest of derivatization reagents are either expensive to 
acquire or are not commercially available. Another reagent which, to the best of our 
knowledge, has never been employed in a metabolomics study is 9-
fluorenylmethyloxycarbonyl chloride (FMOC-Cl). FMOC is well known for reacting 
almost immediately under mild conditions both with primary and secondary amines, 
yielding stable compounds [31]. Although FMOC as a labelling molecule has been 
employed in the determination of amino acids and/or amines in plant roots [32] and 
forensic fingerprints by LC-MS [33], its application to the analysis of plasma, which is 
one of the most widely analyzed samples in metabolomics, has been carried out only 
with UV [34,35] or fluorescence detection [36-38]. Therefore, it could be interesting to 
evaluate its potential as derivatization reagent in the study of the metabolic profiles of 
highly hydrophilic metabolites in plasma samples. With this aim, a LC-MS 
methodology enabling the determination of as many amino acids and amines as possible 
must be developed, so that it can be extrapolated to the study of hydrophilic compounds 
in an untargeted approach. 
Another key point in metabolomics studies is the sample preparation, in which 
protein elimination is an often required step due to the fact that proteins severely 
damage the ionization in mass spectrometry due to ion suppression and they shorten 
column life. Plasma is known to be a highly protein-rich sample (generally up to 8 g of 
protein per dL can be found in this matrix [39]). Among the protein elimination 
procedures used in LC-MS metabolomics studies, the precipitation with organic 
solvents is the strategy of choice [40]. This protocol also offers the possibility of 
breaking protein-metabolites bonds so that the metabolite stays free in the sample 
matrix [41]. However, as it does not eliminate the full protein content from the sample, 
several problems can occur such as ion suppression, ion source contamination, column 
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spoiling, and loss of metabolites if they co-precipitate with the proteins. Other approach 
to eliminate proteins is the ultrafiltration through cut off membranes (from <3 to <30 
kDa). Ultrafiltration advantages comprise obtaining cleaner and more stable samples 
than protein precipitation although it also has disadvantages such as loss of hydrophobic 
metabolites and metabolites which are bound to proteins [41]. 
In this work, the retention behavior of 35 highly polar compounds (amines and 
amino acids) is studied, first, in polar stationary phases without using a derivatization 
step, and then, in a C18 column prior FMOC-derivatization. Once the most suitable 
conditions are found, different sample preparation procedures are evaluated in order to 
select what is better in terms of extracting the largest number of metabolites from 
plasma samples with the lowest variability from sample-to-sample.  
 
2. Materials and methods 
2.1. Reagents and standard solutions 
 All reagents were of analytical grade. MS-grade acetonitrile and methanol were 
obtained from Scharlau Chemie (Barcelona, Spain) while boric acid, formic acid, 
ammonium carbonate, ammonium hydroxide, sodium hydroxide, pentane, and FMOC 
were from Sigma (St. Louis, MO, USA). Isoflurane was from Abbott (Madrid, Spain). 
Glycine (Gly), γ-aminobutyric acid (GABA), histamine (Him), serotonin (5-
HT), taurine (Tau), dopamine (DA), β-alanine (β-Ala), L-alanine (Ala), L-epinephrine 
(EP), L-histidine (His), L-methionine (Met), L-norepinephrine (NE), L-norleucine 
(Nle), L-norvaline (Nva), L-arginine (Arg), L-asparagine (Asn), L-aspartic acid (Asp), 
L-citrulline (Cit), L-cystine (Cys), L-3,4-dihydroxyphenylalanine (DOPA), L-glutamic 
acid (Glu), L-glutamine (Gln), L-isoleucine (Ile), L-leucine (Leu), L-lysine (Lys), L-
ornithine (Orn), L-proline (Pro), L-pyroglutamic acid (Pyr), L-serine (Ser), L-theanine 
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(The), L-threonine (Thr), L-tryptophan (Trp), and L-valine (Val) were acquired in 
Sigma (St. Louis, MO, USA). L-phenylalanine (Phe) and L-tyrosine (Tyr) were from 
Fluka (Buchs, Switzerland). 
A pool containing these 35 compounds dissolved in 300 µL of 200 mM sodium 
borate (pH 9.0) was derivatized with 300 µL of a solution of 10 mM FMOC in 
acetonitrile. After 2 min, 600 µL of pentane was employed to eliminate the excess of 
FMOC, 400 µL from the lower fraction were diluted with 400 µL of water and 200 µL 
of acetonitrile, and mixed properly, to be then injected into the system, so that the final 
concentration of each analyte was 27 µM. In the cases where derivatization was not 
needed the pool of analytes injected had the same final concentration. 
 
2.2. LC-MS conditions 
 Experiments were carried out using a 1100 series HPLC system (Agilent 
Technologies, Germany) coupled to a 6530 series quadrupole time-of-flight (QTOF) 
mass spectrometer (Agilent Technologies, Germany) equipped with a Jet Stream 
orthogonal electrospray ionization (ESI) source. The HPLC system consisted of a 
degasser, a quaternary pump, an automatic injector, and a thermostatic column 
compartment. Agilent Mass Hunter Qualitative Analysis software (B.07.00) was used 
for MS control, data acquisition, and data analysis. During all analysis, two reference 
masses were used, m/z 121.0509 (C5H4N4) and m/z 922.0098 (C18H18O6N3P3F24) for 
positive ionization mode, and m/z 112.9856 (C2O2F3(NH4)) and m/z 1033.9881 
(C18H18O6N3P3F24) for negative ionization mode, which were continuously infused into 
the system to allow mass correction. 
Analysis was completed at 40 ºC using different columns: two from Ascentis 
Express (Sigma, St. Louis, USA), with the same dimension (100 x 2.1 mm) and type of 
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packed bed (fused-core® particles with 0.5 µm thick porous shell and an overall particle 
size of 2.7 µm) but having different stationary phases (C18 or HILIC OH5), and a 
pentafluorophenyl (PFP) Kinetex column from Phenomenex (Torrance, CA, EEUU) of 
150 x 3 mm having particles with 0.5 µm thick porous shell and an overall particle size 
of 2.6 µm. In addition, guard columns (5 x 2.1 mm) of the same material as the 
analytical column in each case were employed. The system operated with an injected 
volume of 10 μL and a flow rate of 0.4 mL/min. 
The optimal working conditions were obtained with the C18 column, in which 
the mobile phases consisted of 0.1% formic acid in Milli-Q water (eluent A) and 0.1% 
formic acid in acetonitrile (eluent B). The linear gradient was set from 5% B to 100% B 
in 30 min, 100% B for 5 min and returned to starting conditions in 1 min, keeping the 
re-equilibration at 5% B for 15 min. The ionization source conditions were as follows: 
capillary voltage of 3000 V with a nozzle voltage of 0 V; nebulizer pressure at 35 psig; 
sheath gas of jet stream of 6.5 L/min at 275 ºC; and drying gas of 10 L/min at 275 ºC. 
The fragmentator (cone voltage after capillary) was set at 175 V. The skimmer and 
octapole voltages were 60 V at 750 V, respectively. MS analysis was performed in 
positive ESI mode with mass range set at m/z 70-1600 (extended dynamic range) in full 
scan resolution mode at a scan rate of 2 scans per second. 
 
2.3. Animal sampling 
Four Wistar rats (Barcelona, Spain) were housed at a constant temperature (20 ± 
2 °C) on a 12-hour light/dark cycle (lights on at 08:00 hours), with ad libitum access to 
food and water. Animals were maintained and handled according to European Union 
guidelines for the care of laboratory animals (Directive 2010/63/EU) and the “Principles 
of laboratory animal care” were followed. All procedures were approved by the 
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bioethics committee of the Universidad Nacional de Educación a Distancia (Madrid, 
Spain). Rats were anesthetized with isoflurane and decapitated, and blood was collected 
in heparinized tubes, centrifuged for 10 min at 2000 x g (4 ºC) and plasma was collected 
and stored at −70°C until sample treatment. 
 
2.4. Plasma treatment: protein elimination and derivatization 
Protein precipitation (PP) method: acetonitrile was added to plasma (3:1, v/v) 
and then vortexed for 30 s and left still for an hour in an ice bath. Samples were 
centrifuged at 10.000xg for 15 min at 4 ºC. 100 µL of 20 mM FMOC in acetonitrile 
were added to a 100 µL 1:1 (v/v) mixture of plasma to 200 mM sodium borate (pH 9.0). 
Samples were then vortexed for 2 min and 200 µL of pentane were added to eliminate 
the excess of labelling reagent [31]. After mixing vigorously, samples were left still for 
a minute and the lower fraction was taken to be analyzed. 
Ultra-filtration (UF) method: a mixture of methanol and 400 mM sodium borate 
(pH 9.0) (1:1, v/v) was added to plasma (1:1, v/v), then it was vortexed for 30 s and it 
was left still for 10 min in an ice bath. Samples were centrifuged at 10000xg for 15 min 
at 4 ºC. The supernatant was vortexed for 30 s to be then ultra-filtered through a 3 kDa 
cut-off filter (Amicon Ultra Filters, Merck, Darmstadt, Germany) at 14000xg for 25 min 
at 4 ºC. 100 µL of the filtrate were mixed with 100 µL of 20 mM FMOC in acetonitrile. 
As in the protein precipitation method, samples were then vortexed for 2 min and 200 
µL of pentane were added to eliminate the excess of labelling reagent [31]. After mixing 
vigorously, samples were left still for a minute and the lower fraction was taken to be 
analyzed. 
 
2.5. Data processing and statistical analysis 
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 Molecular Feature Extraction (MFE) tool from Mass Hunter Qualitative 
Analysis (B.07.00) was employed to obtain time and mass abundances coming from 
chromatographic peaks. MFE algorithm was used to group ions related by charge-state 
envelope, isotopic distribution and the presence of adducts (H+, Na+, and K+ in positive 
ionization mode and HCOO- in negative mode), dimers and ions that belong to the same 
compound (e.g. FMOC species). Other parameters include “small molecules 
(chromatographic)” as extraction algorithm, ions with more than 500 counts were 
considered, peak spacing tolerance=0.01 m/z, plus 10.0 ppm; isotope model=common 
organic molecular; limited assigned charge =2. 
 Once molecular features were extracted; alignment and filtering were carried out 
by means of the Agilent Mass Profiler Professional tool (B.02.00). Retention time data 
range was set from 2 min; mass tolerance 15 ppm with a mass window of 0.02 Da and a 
retention time window of 0.2. Multivariate statistical analysis was carried out using 
SIMCA 13.0 (Umetrics, Umeå, Sweden).  
 
3. Results and discussion 
3.1. Study of the interaction of the studied hydrophilic analytes with different stationary 
phases 
 It is well known that highly polar compounds cannot be retained in RPLC 
columns and, as a result, they elute with the column dead volume making it difficult to 
carry out the proper determination in a complex matrix. It is a fact that in most of 
samples with high importance, such as biological samples (e.g. urine or plasma [43]) or 
even samples from other sources (e.g. foodstuffs or beverages [44]), the amount of polar 
compounds is elevated. Thus, the development of analytical methodologies enabling the 
determination of highly polar compounds in this kind of matrices is necessary being LC 
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with high resolution MS detection a powerful tool to face this task due to its robustness, 
high sensitivity and excellent selectivity. 
In this work, a group of 35 highly polar compounds that comprise proteinogenic 
and non-proteinogenic amino acids, and several biogenic amines (see section 2.1) was 
selected. In order to determine these compounds by LC-MS, their interactions with 
different stationary phases under different chromatographic conditions were 
investigated using a pool containing standard solutions of the 35 studied compounds. 
The purpose of this optimization protocol was to obtain the optimal conditions for the 
retention and separation of these compounds but under general gradient conditions so 
that it can be further applied to carry out untargeted metabolomics studies. The 
interaction of the underivatized analytes was evaluated in columns with less 
hydrophobicity than the standard C18, such as pentafluorophenyl (PFP) and HILIC, and 
the results obtained were compared with those corresponding to the determination of the 
FMOC-labeled analytes in a C18 column. 
The first column evaluated was a PFP column, a fully-wettable column that 
offers different interactions mechanisms such as hydrophobic, π-π, electrostatic, and 
hydrogen bond interactions, and that is suitable both for low-polar and mid-polar 
compounds. Regarding this column, fully-aqueous conditions can be employed, so first 
a gradient from 0 to 100 % of B in 30 min being eluent A water and eluent B 
acetonitrile, both with 0.1 % formic acid, was tested. This set of conditions enabled the 
retention of only 12 of the 35 compounds studied, 17 compounds had no retention (they 
eluted with the dead column volume), and 6 compounds were not detected. In order to 
improve retention in the PFP column, methanol was used as organic modifier instead of 
acetonitrile. The new mobile phase based on methanol offered better retention and 16 of 
the 35 compounds studied were retained, 13 compounds had no retention, and 6 
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compounds were not detected. Once methanol was selected as organic solvent in phase 
B with the PFP column, 10 mM ammonium acetate was used instead of formic acid, i.e. 
more basic conditions, and this new mobile phase offered a better retention as 20 of the 
35 compounds studied were retained, whereas that 14 compounds had no retention, and 
only 1 compound was not detected. 
The second column evaluated was a HILIC column using a method reported by 
Qi et al. for determination of polar compounds [45], thus a gradient elution from 100 to 
55 % of B, being the eluent A 10 mM ammonium formate and 0.2 % formic acid in 
water and the eluent B 95% acetonitrile and 5% of 2 mM ammonium formate and 0.2 % 
formic acid in water [45]. It is remarkable to point out that when comparing the best 
conditions of PFP and the conditions described for HILIC, HILIC offered a better 
analytical performance as it enabled to obtain a larger number of compounds retained in 
this stationary phase (29 of the 35 studied compounds), although the signal intensity 
was higher in the case of the PFP column. 
Due to the fact that none of the tested conditions enabled the retention of all the 
compounds of interest another strategy had to be assayed. As stated in the introduction, 
by labelling the studied analytes their hydrophobicity can be enhanced and therefore 
their interaction with a RPLC stationary phase, a traditional C18 column, can be 
stronger resulting in their retention onto this kind of stationary phases. Here we studied 
the potential of FMOC to enhance the retention of the studied analytes due to its 
numerous advantages as forming stable compounds rapidly. Chromatographic 
conditions consisted of a gradient from 5 to 100 % of B in 30 min being eluent A water 
and eluent B acetonitrile, both with 0.1 % of formic acid. These new conditions offered 
the best results since 33 of the 35 compounds studied were retained (only The and Pyr 
were not detected), this being the largest number of compounds found so far. Also, note 
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that under these conditions isomeric molecules could be perfectly separated 
(Leu/Ile/Nle, Val/Nval, and Ala/β-Ala), unlike under any of the conditions previously 
tested. As expected, when comparing the peak shapes obtained with the other columns, 
the efficiency of the strategy based on the C18 column with FMOC-derivatization was 
far better than the one obtained with the underivatized analytes in the HILIC and PFP 
conditions. As expected, the retention of the studied compounds was substantially 
greater in the C18 column (all compounds eluted between 9 and 19 min) when 
compared to the PFP (compounds eluted between 2 and 11 min) and the HILIC 
(compounds eluted between 5 and 14 min). In addition, the fact that the studied 
compounds in C18 eluted at higher % of the eluent B also implied a sensitivity 
improvement as a higher content of organic solvent in the mobile phase is associated 
with higher MS ionization efficiency. 
Regarding the MS conditions employing the C18 column, the number of 
compounds in positive (mobile phase with 0.1 % of formic acid) and negative (mobile 
phase with 10 mM ammonium acetate) ionization modes was not so different, but the 
sensitivity obtained in the positive mode was much higher for all analytes except for 
Ser, Tau and Asp whose sensitivity was slightly higher in the negative mode. According 
to the obtained results, we concluded that the best conditions for the C18 column were 
the ones in the positive ionization mode. Under these conditions, it is important to note 
that the chemical FMOC-labelling provides a signature that is easily distinct by MS as 
the studied compounds were detected as ions derived from the complex with FMOC 
([M+FMOC+H]+, [M+FMOC+Na]+ and [M+FMOC+K]+) whereas the [M+H]+ specie 
was observed for all the studied compounds except for Arg, Cys, Orn, His, and Him. 
This is of special importance due to the fact that in an untargeted metabolomic strategy 
the molecular feature extraction algorithm needs to detect both, the [M+H]+ and the 
15 
 
[M+FMOC]-derived species to identify them as the same compound. Thus, in order to 
also obtain the [M+H]+ the temperature of the ion source and cone voltage after 
sampling capillary and before the ion optics (called fragmentator) needed to be 
optimized. Different fragmentator voltages (50, 100, 175, and 225 V) and sheath gas 
and nebulizer temperatures (275, 300, and 325 ºC) were investigated where 175 V and 
275 ºC proved to be the optimal conditions as it was the only combination in which all 
of the 35 compounds could be finally detected, in addition to the detection of the 
[M+H]+ specie of every single analyte (see Fig. 1A). Note that this optimization was 
also carried out for non-derivatized analytes in the HILIC column to see if we could 
increase the number of detected analytes but this was not the case. The best conditions 
of HILIC, in terms of the number of compounds determined and sensitivity were the 
initial conditions (100 V of fragmentator and 300 ºC of sheath gas and nebulizer 
temperatures) (see Fig. 1B). 
As shown in Fig. 1A, two different retention time windows are well 
differentiated, one from 9 to 19 min in which all 35 compounds derivatized with a 
molecule of FMOC eluted, and the other window, from 20.5 to 22 min for those 
analytes which reacted with two molecules of FMOC (Cys, Orn, His, and Lys). This 
means that in a time window of only 10 mins, 35 compounds could be determined (for 
those derivatized with a molecule of FMOC), so in case only these compounds were to 
be followed, for example, in a targeted strategy, gradient can be modified to speed up 
the chromatographic separation. However, as the aim of this work was to propose a 
method to separate highly polar compounds for a future untargeted metabolomics 
approach, general linear gradient conditions were employed. 
 
3.2. Treatment of plasma samples 
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 Due to the fact that plasma reflects global changes in the metabolism, rat plasma 
was chosen as test sample to show the versatility of the developed LC(C18)-MS 
methodology employing FMOC as derivatization reagent. 
First, the concentration of FMOC necessary to label all the compounds existing 
in the sample was studied. 50 µL of plasma were mixed with 50 µL of 400 mM borate 
(pH 9.0) and were derivatized with 100 µL of FMOC in acetonitrile at different 
concentrations (from 1 to 40 mM). The studied compounds had nearly the same 
behavior: peak area increased until 5-10 mM of FMOC and then it was kept practically 
constant until 40 mM. Therefore, we selected 20 mM to ensure that all amino-
containing analytes were completely derivatized. It is important to highlight that FMOC 
derivatization was completed in just 2 min at room temperature, this being the main 
advantage of FMOC when compared to other derivatization reagents that have been 
used in metabolomics-related studies. DBD-F needed reaction times of 30 min at 30 ºC 
[28], AQC 15 min at 55 ºC [19], aminooxy-N-(3-perfluorooctyl)acetamide overnight at 
70 ºC [22], Rub2m-O-Su 1.5 h at 55 ºC [23], and DNS 1 h at 60 ºC [27,28]. Exposing 
samples to high temperatures could, additionally, lead to thermal degradation of the 
metabolites of interest, so working at room temperature should offer a better sample 
stability. 
 Second, the procedure to eliminate proteins from plasma was investigated. As 
stated in the introduction, PP is the strategy most widely employed even though UF 
offers promising results [41]. As both strategies offer advantages the use of UF with a 
previous step of addition of organic solvent enough to break metabolite-protein bonds 
was investigated and compared with the widely applied method based on PP with an 
organic solvent. Thus, four rat plasma samples were pooled and, on the one hand, five 
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aliquots were individually treated by the PP method and, on the other hand, another five 
aliquots of plasma were treated by the UF method, both according to section 2.4. 
 Fig. 2 shows the total ion chromatograms (TICs) of a representative analysis 
from each treatment where it is noticeable that the TIC signal of the UF sample is 
higher than that of the PP procedure, this is mainly caused by the fact that plasma 
treated by the PP method had to be diluted four times with organic solvent, this being 
the main drawback of the PP strategy. Moreover, Fig. 3a shows the extracted 
chromatogram of the 35 investigated hydrophilic compounds in a rat plasma sample 
treated with the UF strategy in which 30 out of 35 compounds studied could be detected 
(all except DA, DOPA, EP, Nle and The). Note that the PP strategy also offered a lower 
number of the followed compounds was obtained, as Him, Cys, Tau, GABA, NE, and 
Nval could not be detected (see Fig. 3b), compounds which could be determined in 
samples treated with the proposed UF strategy. 
 On the other hand, molecular features from both groups (UF and PP), extracted 
according to section 2.5, were filtered by retaining those components having a signal 
larger than 10000 counts, which were present in all the samples of each group, and 
whose RSD % was not higher than 35 %. Fig. 4 displays the Venn diagram with the 
features that met these filtering conditions and that are unique and common for the two 
sample treatments, where it can be seen that the UF approach enabled to obtain up to 7-
times more unique features than the PP treatment (4631 vs 666). Additionally, when 
plotting a principal component analysis (PCA) of the common features found in the 
samples studied (745 features), it can be observed the clear separation among these two 
groups in the first principal component but, above all, it is noteworthy the fact that the 
UF samples clustered tighter than samples of PP that remained more dispersed. This 
clearly demonstrated that the features obtained by the UF approach had lower variability 
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from sample to sample when compared to the PP method. Additionally, when taking 
into account the RSD of peak areas of the group of amino acids and amines that were 
followed in this work and that were present in both strategies, again, it can be seen how 
the UF method offered much lower variability when compared to PP (from 2 to 12 
times lower variability found in UF for these compounds, except for β-Ala whose RSD 
was slightly higher in UF) (see Table 1). Due to the fact that the UF allowed to obtain a 
larger number of molecular features with lower variability, attributes of high importance 
in any metabolomics approach, it was chosen for further studies. 
 
3.3. Precision and sample stability assessment 
An important issue to take into account is to evaluate the precision and the 
sample stability of the developed strategy, as when metabolomics studies need to be 
carried out, precise methods must be used to assure that the differences are due to real 
biological variabilities and not to instrumental or methodological fluctuations. Thus, 
instrumental and method repeatability, intermediate precision, and sample stability were 
determined for the 30 compounds found in the ultra-filtered plasma. 
First, instrumental repeatability was assayed as the triplicate injection of a 
derivatized plasma sample. As shown in Table 2, RSD values for all peak areas were 
generally below 5 % and below 0.2 % for the retention times (RT). Regarding method 
repeatability, evaluated from the injection in the same day of three individual plasma 
samples individually derivatized, RSD values for peak areas were below 10.8 % 
whereas that in the case of RT, once again, they were below 0.2 %. The intermediate 
precision in a three days assessment was evaluated as the duplicate injection of a sample 
derivatized each of the three days. RSD values of peak areas were in all cases below 15 
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% except for Asp which was slightly higher, and again, RSD values for RT were below 
0.2 %. 
Another important aspect is to study how stable plasma samples are at room 
temperature once they have been derivatized with FMOC. To address this issue, a single 
plasma sample was derivatized and was injected six times in a time span of 16 h. Except 
for few exceptions, RSD values of peak areas were below 10 %, and in all cases RSD 
values for RT were below 0.2 % (see Table 2), thus, samples are considered stable at 
least for 16 h at room temperature. This highlights the suitability of the proposed 
methodology to be applied in metabolomics studies. 
 
 
4. Concluding remarks 
 In this work, the use of FMOC as labelling agent is shown to offer better 
performance in the determination of a group of 35 polar compounds (amino acids and 
amines) in a C18 column, when compared to other polar stationary phases such as PFP 
or HILIC, not only in number of retained compounds but also in terms of sensitivity and 
peak efficiency, under the assayed conditions. 
The developed LC(C18)-MS methodology was applied to the analysis of plasma 
samples, due to the high interest in the analysis of this matrix, especially in the 
metabolomics field. It was found that the ultrafiltration strategy enabled to obtain a 
larger number of compounds with a lower variability from sample to sample when 
compared to the protein precipitation method. The three different precision studies 
(instrumental and method repeatability, and intermediate precision) and the stability 
study performed on the plasma samples gave adequate results. Therefore, it has been 
demonstrated that the proposed methodology is superior to the other assayed conditions 
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regarding plasma treatment and chromatographic conditions in the detection of polar 
compounds. 
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Fig. 1. Extracted Compound Chromatograms obtained under the optimal conditions for 
(A) FMOC-derivatized analytes in C18 and (B) non-derivatized analytes in HILIC. 
Chromatographic conditions are detailed in the text. xLeu and xVal are used when 
identification of the isomers of these compounds was not carried out. 
Fig. 2. Total Ion Chromatograms (TIC) of the same rat plasma sample deproteinized by 
protein precipitation (PP) and ultrafiltration (UF). 
Fig. 3. Extracted Compound Chromatogram of the investigated hydrophilic compounds 
in a plasma sample treated with (a) ultrafiltration strategy and (b) protein precipitation 
strategy, both analyzed by means of the LC(C18)-MS methodology. 
Fig. 4. Venn diagram displaying the unique and common molecular features found in 
the protein precipitation and ultrafiltration strategies, and PCA score plot having the 
































Table 1. RSD (%) values obtained for peak areas for the compounds determined in 
plasma by the PP and UF methodologies. 
Analytes 
RSD (%) of peak areas (n=5) 
PP UF 
Alanine 8.4 3.6 
β-alanine 9.1 10.0 
Arginine 16.6 3.6 
Asparagine 13.4 3.9 
Aspartic acid 18.7 8.0 
Citrulline 17.2 3.1 
Glutamic acid 24.4 2.3 
Glutamine 11.1 1.3 
Glycine 14.1 8.3 
Histidine 43.7 21.3 
Lysine 24.8 2.0 
Methionine 25.9 3.8 
Leucine 23.4 11.8 
Isoleucine 20.9 3.8 
Ornithine 32.6 8.8 
Phenylalanine 22.8 8.3 
Proline 13.5 1.6 
Pyroglutamic acid 47.7 6.1 
Serine 20.5 4.1 
Serotonin 41.4 9.6 
Threonine 9.1 5.5 
Tryptophan 14.5 6.2 
Tyrosine 20.6 5.5 








Table 2. RSD (%) values obtained for peak areas and retention times (RT) for the 
compounds determined in plasma in the instrumental and method repeatability, 


























Alanine 0.9 0.03 0.7 0.1 5.1 0.1 3.1 0.2 
β-alanine 2.8 0.1 5.2 0.1 9.6 0.03 11.6 0.2 
Arginine 1.8 0.04 2.7 0.1 8.6 0.2 6.7 0.2 
Asparagine 1.0 0.04 1.1 0.1 8.8 0.1 6.7 0.1 
Aspartic acid 2.0 0.1 4.3 0.1 17.7 0.1 9.3 0.2 
Citrulline 1.5 0.1 2.3 0.2 7.7 0.1 4.6 0.1 
Cystine 1.8 0.02 1.2 0.1 7.3 0.1 5.5 0.1 
GABA 4.4 0.1 10.3 0.1 13.2 0.1 14.1 0.2 
Glutamic acid 0.8 0.1 1.5 0.1 11.1 0.1 4.2 0.2 
Glutamine 0.6 0.2 0.7 0.1 2.8 0.03 2.7 0.1 
Glycine 1.6 0.1 1.3 0.1 10.4 0.1 5.4 0.2 
Histamine 8.9 0.1 10.6 0.1 12.3 0.1 10.9 0.1 
Histidine 4.3 0.1 7.0 0.05 12.0 0.1 7.9 0.2 
Lysine 1.0 0.02 2.8 0.1 3.7 0.1 2.9 0.04 
Methionine 0.9 0.02 3.7 0.1 7.9 0.05 5.6 0.1 
Norepinephrine 2.0 0.1 8.0 0.1 11.2 0.1 6.3 0.2 
Norvaline 5.2 0.04 5.3 0.1 12.5 0.1 8.8 0.1 
Leucine 4.3 0.02 7.5 0.1 8.5 0.1 5.2 0.1 
Isoleucine 3.0 0.04 4.0 0.04 9.3 0.1 4.2 0.1 
Ornithine 4.7 0.1 6.9 0.1 12.7 0.1 11.6 0.1 
Phenylalanine 2.0 0.1 5.1 0.1 7.4 0.1 4.5 0.1 
Proline 0.3 0.02 0.4 0.1 8.7 0.04 3.9 0.1 
Pyroglutamic acid 2.0 0.1 3.1 0.1 12.4 0.1 8.2 0.2 
Serine 1.2 0.1 1.1 0.1 4.5 0.1 2.0 0.2 
Serotonin 5.2 0.04 7.9 0.1 12.1 0.1 7.2 0.1 
Taurine 0.9 0.1 2.0 0.1 15.2 0.1 8.4 0.2 
Threonine 1.7 0.03 8.0 0.1 11.6 0.1 7.8 0.2 
Tryptophan 1.3 0.02 6.3 0.1 6.8 0.03 5.0 0.1 
Tyrosine 3.8 0.03 10.8 0.1 9.7 0.1 13.5 0.2 
Valine 0.1 0.04 1.7 0.1 6.9 0.1 4.9 0.1 
